Announcement of Chenxin Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2025
Securities code: 603367 Securities abbreviation: Chenxin Pharmaceutical Announcement number: 2025-060
Chenxin Pharmaceutical Co., Ltd.
Announcement on Convening the Third Quarter 2025 Results Briefing
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: November 26, 2025 (Wednesday) 09:00-10:00
Meeting location: Shanghai Stock Exchange SSE Roadshow Center (Website: https://roadsho w.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the SSE Roadshow Center website before 16:00 on November 21, 2025 (Friday) to November 25 (Tuesday) and click on the "Question Pre-Collection" column or ask questions through the email address of Chenxin Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") at [email protected]. The company will answer questions of common concern to investors at the briefing.
The company has released the company's 2025 third quarter report on October 28, 2025. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2025 third quarter operating results and financial status, the company plans to hold a 2025 third quarter performance briefing on November 26, 2025 (Wednesday) 09:00-10:00 to communicate on issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in an interactive online format. The company will interact and communicate with investors on the specific operating results and financial indicators in the third quarter of 2025, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: November 26, 2025 (Wednesday) 09:00-10:00
(2) Meeting location: Shanghai Securities Roadshow Center
(3) Meeting method: SSE Roadshow Center online interaction
3. Participants
Chairman and general manager Mr. Du Zhenxin, financial director and board secretary Mr. Xu Xinbing, independent director Mr. Zhang Ziran and staff of the securities department (if there are special circumstances, the number of participants may be adjusted).
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) via the Internet from 09:00-10:00 on November 26, 2025 (Wednesday) to participate in this performance briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log in to the homepage of the SSE Roadshow Center website from November 21, 2025 (Friday) to November 25 (Tuesday) before 16:00, click on the "Pre-Solicitation for Questions" column (https://road show.sseinfo.com/preCallQa), and select this event according to the event time or email the company at [email protected] Ask the company questions and the company will answer questions of common concern to investors at the briefing.
5. Contact person and consultation method
Contact person: Sun Wei
Tel: 0537-2989906
Email: [email protected]
6. Other matters
After the investor briefing is held, investors can check the status and main content of the investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Chenxin Pharmaceutical Co., Ltd.
November 20, 2025